Pembrolizumab
id:
pembrolizumab-165-1030994
title:
Pembrolizumab
text:
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 Inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is administered by slow intravenous injection. Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea, nausea, rash, fever (pyrexia), cough, difficulty brea
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug used in cancer treatment
original url:
https://en.wikipedia.org/wiki/Pembrolizumab
date created:
2013-04-24T22:30:38Z
date modified:
2024-08-29T06:24:04Z
main entity:
{"identifier":"Q13896859","url":"https://www.wikidata.org/entity/Q13896859"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/98/Pembrolizumab_5DK3.png","width":2048,"height":2048}
fields total:
13
integrity:
16